AC Immune, Genentech, Roche deal

AC Immune will receive a CHF14 million ($14.4 million) milestone

Read the full 104 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE